Search

The health pipeline of AseBio includes 130 molecules for 150 indications being investigated by 40 national companies, with oncology as the majority area. Additionally, 47 AseBio partner entities are

The biopharmaceutical company has been invited to participate or attend different events of reference within the biotechnology industry.

AseBio will participate as a member and coordinator, respectively, in different delegations representing Spain at two important events: the Anglo Nordic Life Sciences conference and Swiss Biotech Days

While not yet a global player, Artificial Intelligence (AI) is increasingly being integrated into the healthcare landscape in Spain, with the potential to significantly enhance patient care and

La compañía biofarmacéutica ya ha sido inscrita en el Registro de Público de PYMES INNOVADORAS.

The Barcelona Science Park awarded the prizes for the 20th BATX2LAB, an initiative within the PCB RESSÒ programme that allows students in their first year of upper secondary school to carry out the

Applications in biotechnology have experienced a growth of 6.1% compared to the previous year, according to the latest report from the European Patent Office.

BIOLAN is committed to continuously innovate and improve its platform to meet the changing needs that the market presents.

Real-world evidence (RWE) is a promising source of data that could help to accelerate drug access in rare diseases.

On June 12 and 13, Vigo will become the capital of biotechnology for the celebration of the II edition of "Galicia Biodays", the reference forum for the biotech and life sciences industry.

This project, coordinated by Asebio, brings together ZeClinics' target validation and in vivo drug screening capabilities, Celtarys Research's scientific knowledge in fluorescent tool design and

We consider it a priority to accelerate its implementation and broaden its scope of action to enhance and promote the development of biotechnology and bio-manufacturing, which are key to achieving

A public-private consortium, led by the Spanish biotech company Hemostatics, located in the Barcelona Science Park, and involving the Clínica Universidad de Navarra (CUN) and the Institute of Chemical

The Spanish pharmaceutical company has obtained global rights to develop and commercialize the drug ZKN-013.

Biotechnology provides solutions through plant genetic engineering, the revaluation of food industry by-products, new food sources and biofuels, among others.

On the occasion of World Tuberculosis Day, we delve into the advances achieved by the candidate vaccine against tuberculosis MTBVAC.

This Thursday, March 21, Konexio Biotech, represented by its CEO, Andrea Romero, participated in the 'First Day of Inspection and Control of Medicines AEMPS & AEFI'.

In the case of Spain, we have the National Certification Center for Medical Devices as a notified body for medical devices under Regulation (EU) 2017/745, but it has not been designated for Regulation

The vast diversity of resources provided by the still greatly unknown marine ecosystem has significant applications in fields such as food, cosmetics, fertilizers and biostimulants, biomaterials

BCN HEALTH publica un estudio en la revista Plos ONE sobre los datos de incidencia a nivel hospitalario y los costes médicos asociados del cáncer de próstata en España.

La ‘I Jornada Genusal. Impulsando la perspectiva de género en salud’ trató las diferencias de salud según el género, poniendo de manifiesto la necesidad de las mujeres y evitar los sesgos de sexo que